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Abstract:  In  order  to  obtain  structural  features  of  3-arylpyrimidin-2,4-diones  emerged   
as  promising  inhibitors  of  insect  γ-aminobutyric  acid  (GABA)  receptor,  a  set  of 
ligand-/receptor-based  3D-QSAR  models  for  60  derivatives  are  generated  using 
Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity 
Index  Analysis  (CoMSIA).  The  statistically  optimal  CoMSIA  model  is  produced  with 
highest  q
2  of  0.62,  r
2
ncv  of  0.97,  and  r
2
pred  of  0.95.  A  minor/bulky  electronegative 
hydrophilic polar substituent at the 1-/6-postion of the uracil ring, and bulky substituents at 
the 3'-, 4'- and 5'-positions of the benzene ring are beneficial for the enhanced potency of 
the  inhibitors  as  revealed  by  the  obtained  3D-contour  maps.  Furthermore,  homology 
modeling, molecular dynamics (MD) simulation and molecular docking are also carried 
out to gain a better understanding of the probable binding modes of these inhibitors, and 
the results show that residues Ala-183(C), Thr-187(B), Thr-187(D) and Thr-187(E) in the 
second  transmembrane  domains  of  GABA  receptor  are  responsible  for  the  H-bonding 
OPEN ACCESS Int. J. Mol. Sci. 2011, 12                         
 
6294
interactions  with  the  inhibitor.  The  good  correlation  between  docking  observations  and 
3D-QSAR  analyses  further  proves  the  model  reasonability  in  probing  the  structural 
features and the binding mode of 3-arylpyrimidin-2,4-dione derivatives within the housefly 
GABA receptor. 
Keywords: 3-arylpyrimidin-2,4-diones; GABA receptor; 3D-QSAR; homology modeling; 
molecular dynamics simulation; molecular docking 
 
1. Introduction 
As  ligand-gated  chloride  channels  that  belong  to  the  Cys-loop  receptor  family,  ionotropic 
γ-aminobutyric  acid  (GABA)  receptors  are  widely  distributed  throughout  the  vertebrate  and 
invertebrate  central  nervous  system  where  they  predominantly  mediate  the  effects  of  inhibitory 
neurotransmitter  GABA  [1–3].  The  ionotropic  GABA  receptor  exists  as  pentameric  membrane   
protein  [4],  with  each  subunit  consisting  of  an  N-terminal  extracellular  domain,  four  α-helical 
transmembrane (TM) domains, where the TM2 domain lines the integral chloride channel, and a large 
intracellular loop between TM3 and TM4 [5]. In insect, researchers have cloned three kinds of subunits 
of ionotropic GABA receptors: Rdl (resistant-to-dieldrin), LCCH3 (ligand-gated chloride channel 3) 
and GDR (the GABAA and glycine receptor-like subtype of Drosophila), wherein the Rdl is the unique 
subunit known to form functional GABA-gated channel, suggesting its tendency to be a major subunit 
of the insect GABA receptor [5,6]. 
Insect GABA receptors are the molecular targets of non-competitive antagonist insecticides, such as 
fipronil  and  picrotoxinin,  which  have  been  widely  applied  in  pest  insect  control  by  exerting  their 
effects on insect GABA receptors by way of decreasing the Cl
− inﬂux into the neurons [7–11]. The 
polychlorocycloalkane  lindane  and  dieldrin  are  classical  chlorinated  insecticides,  which  have  been 
banned due to their persistence in the environment and their resistance to the insects [6]. Fortunately, 
phenylpyrazole  fipronil,  a  major  replacement  insecticide  acting  at  the  GABA  receptor,  has  been 
successfully developed showing excellent selectivity and activity for insect chloride channels, as well 
as low mammalian toxicity and low persistence in environment [12]. However, due to its extensive or 
inappropriate use nowadays, fipronil has exhibited undesirable threats on birds [13,14] and aquatic 
organisms  [15].  Therefore,  the  development  of  new  GABA  chloride  channel  insecticides  as  an 
alternative is still urgent for the pest insect control recently.   
On GABA receptor, the binding assays of site-directed mutants indicate that amino acids Ala2', 
Thr6' and Leu9' at the TM2 region of GABA receptor might be involved in the interactions with those 
non-competitive antagonists (NCAs) [10,12,16]. However, some other evidences also suggested that 
the structurally diverse NCAs might have distinct binding modes in GABA receptor [2,17,18]. For 
instance, ﬁpronil might bind to the TM3 while picrotoxinin and dieldrin bind to the TM2 region of 
GABA receptor [2]. However, it still remains ambiguous whether all NCAs with diverse structures 
interact at the same or an overlapping site, or multiple sites within the channel pore [16,19]. Recently, 
the replacement of the channel-lining A2' amino acid on the cytoplasmic side (Ala2' to Ser in the   
D. melanogaster Rdl) was also found to confer resistance to diverse insecticides, such as fipronil, Int. J. Mol. Sci. 2011, 12                         
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dieldrin, picrotoxinin and picrodendrin-O [1,6,20]. A radiolabeled-ligand-binding assay showed that 
Thr6' mutation could completely abolish the binding ability of ethynylbicycloorthobenzoate (EBOB) [16]. 
These mutations potentially perturb the gating kinetics and decrease the binding potency of NCAs. 
Besides the experiments probing the structural features of NCAs interacting with GABA receptor, 
in  silico  methods,  such  as  the  three-dimensional  quantitative  structure-activity  relationship 
(3D-QSAR) analysis, have been introduced to analyze several kinds of NCAs, such as endosulfan [19], 
bicyclophosphates [19], and 1-phenyl-1H-1,2,3-triazoles [21]. The speciﬁc structural and electrostatic 
features deﬁned  by the comparative  molecular ﬁeld analysis (CoMFA) and comparative  molecular 
similarity  indices analysis (CoMSIA) are found to be essential  for enhancing the binding of these 
NCAs  in  the  GABA  receptors  [21].  In  addition,  hydrophobicity,  a  possible  factor  controlling  the 
transport behavior of compounds, is also significant in governing variations in insecticidal activity [19]. 
More  recently,  to  quest  new  GABA  chloride  channel  insecticides,  a  series  of   
3-arylpyrimidin-2,4-diones (APDs) have been developed exhibiting equivalent efficacies to fipronil by 
in vitro GABA assay [9]. The in vivo experiments also showed that APDs not only excellent control 
against the southern corn rootworm in the greenhouse but also are insecticidal against the plant hopper, 
rice  leafhopper,  twenty-eight-spotted  lady  beetle  and  two-spotted  spider  mite  with  no  method  of 
analysis disclosed [9]. As mainly concerns are taken into account with the potency of APDs, several 
questions about APDs still remain to be clariﬁed: (1) what  are  the  structural  features  of  APDs 
indispensable for improvement of the potency? (2) how do APDs interact with the insect’s GABA 
receptor at a molecular level? (3) what is the similarity/difference of the binding sites between these 
compounds and other reported NCAs? 
Therefore, to answer the above questions and to explore these key structural features impacting the 
potency of APDs, 3D-QSAR analyses using the CoMFA and CoMSIA methodologies are applied in 
this work on a group of APDs analogues as GABA receptor ligands. In addition, homology modeling, 
molecular docking and molecular dynamics simulation are also performed to elucidate the probable 
binding  modes of these  inhibitors within the GABA receptors. The good consistency  between  3D 
contour maps and the topographical features of the binding sites of APDs leads to our identification of 
the  developed  models,  which  might  provide  useful  information  for  further  guiding  the  structural 
modification and design of new potential APDs insecticides. 
2. Results and Discussion 
2.1. Statistical Analysis 
Ligand- and receptor-based alignment methods were applied to produce the models for CoMFA and 
CoMSIA analysis. In terms of statistical parameters, the q
2 (0.60 and 0.62), r
2
ncv (0.94 and 0.97) and 
r
2
pred (0.82 and 0.95) values obtained from ligand-based models (Table 1) suggest that these models 
had  good  statistical  correlation  and  predictive  capacity.  Additionally,  the  good  consistency  of  the 
ligand-based models between the 3D-QSAR maps and docking results also indicates the robustness 
and reasonability of the models. However, compared with the ligand-based models, the receptor-based 
ones generate the low q
2 (0.34 and 0.55) and r
2
ncv (0.81 and 0.85) values (Table 1), which indicate the 
bad predictive capacity of the receptor-based  models. Moreover, the receptor-based alignment was Int. J. Mol. Sci. 2011, 12                         
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more  scattered than  the  ligand-based  one  (as  shown  in  Figure  1). Thus, the  models  derived  from 
ligand-based alignment are better than those derived from receptor-based one. 
Table 1. Statistical results of CoMFA and CoMSIA models. 
Parameters 
Ligand-Based  Receptor-Based 
CoMFA  CoMSIA  CoMFA  CoMSIA 
q
2 
a  0.60  0.62  0.34  0.55 
r
2
ncv 
b  0.94  0.97  0.81  0.85 
SEE 
c  0.48  0.32  0.78  0.70 
F 
d  90.71  126.18  56.61  45.23 
r
2
pred 
e  0.82  0.95  0.85  0.90 
SEP 
f  1.17  1.22  1.44  1.21 
Nc 
g  6  10  3  5 
Field contribution 
S  0.573  0.139  0.533  0.222 
E  0.427  0.338  0.467  - 
H  -  0.383  -  0.515 
D  -  0.059  -  0.091 
A  -  0.081  -  0.173 
a  Cross-validated  correlation  coefficient  using  the  LOO  methods; 
b  Non-cross-validated  correlation 
coefficient; 
c  Standard  error  of  estimate; 
d  Ratio  of  r
2
ncv  explained  to  unexplained  =  r
2
ncv/(1  −  r
2
ncv);   
e  Predicted  correlation  coefficient  for  the  test  set  compounds; 
f  Standard  error  of  prediction;   
g Optimal number of principal components. 
The CoMFA model describing APDs inhibition using both S and E fields produces a q
2 = 0.60 and 
an r
2
ncv = 0.94 using six optimum components with an F-statistic value (F = 90.71) and a standard 
error of estimate (SEE = 0.48), which signify a good statistical correlation and predictive capacity of 
the model (q
2 > 0.5) [22]. The corresponding contributions of S and E ﬁelds are respectively 57.3%, 
and 42.7%, indicating that the S field has a greater influence than the E field in inhibition potency.   
The external test set of 15 molecules was employed with the purpose of testing the stability and 
predictive ability of the constructed CoMFA model. Compounds 14 and compound 21 regarded as 
outliers were omitted from the final analysis, since their diﬀerences between the experimental and 
predicted pKi values were more than one logarithmic unit. A bulky higher hydrophobic substituent of 
compound 14 and hydrogen substituent of compound 21 at 1-position of the uracil ring might account 
for their outlier status. The predicted correlation coefﬁcients (r
2
pred) for the CoMFA model is 0.82, 
proving its proper capability for prediction of the test inhibitors. The correlation between the predicted 
and experimental pKi values of all compounds in the CoMFA model is shown in Figure 1A. 
In comparison to CoMFA, CoMSIA methodology using the same standard has an advantage of 
exploring more field descriptors for the APDs inhibition. In the CoMSIA model, statistical parameters 
show that S, E, H, D and A features significantly influence the activity of the compounds. The q
2 (0.62), 
r
2
ncv (0.97), SEE (0.32) and F (126.18) values obtained from the model indicate a good predictive 
capacity and internal consistency. In addition, the percentages of the variance explained by S, E, H, D 
and A descriptors are respectively 0.139, 0.338, 0.383, 0.059 and 0.081, implying that the hydrophobic 
field  which  is  not  included  in  the  CoMFA  model  is  important  for  explaining  the  potency  of  the Int. J. Mol. Sci. 2011, 12                         
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molecules. Furthermore, the CoMSIA model possesses better prediction with high r
2
pred (0.95) than 
CoMFA  model  under  the  same  outliers.  The  correlation  between  the  predicted  activities  and 
experimental pKi values is displayed in Figure 1B. Overall, CoMSIA model is more reliably applied 
than the CoMFA model in description of the APDs inhibition and the design of new inhibitors. 
Figure 1. Plot of the predicted pKi versus the experimental pKi values for the models based 
on the training (filled black squares) and test (filled blue rhombuses) sets. (A) CoMFA,   
(B) CoMSIA. The solid line is the regression line for the fitted and predicted bioactivities 
of training compounds. The outliers in test set are shown in orange triangles. 
    
2.2. 3D-QSAR Contour Maps 
To  visualize  the  information  content  of  the  derived  3D-QSAR  models,  CoMFA  and  CoMSIA 
contour maps were generated by plotting the ﬁeld energies at each lattice point as the percentage of the 
contribution to the CoMFA or CoMSIA equation, which were calculated as the scalar results of the 
coefﬁcient and the standard deviation. The colored polyhedra in the map surrounds all those lattice 
points where the 3D-QSAR models strongly associate the changes in the compounds’ ﬁeld values with 
those  changes  in  the  biological  potency.  To  aid  in  visualization,  the  highest  active  compound  58   
(pKi = 9.3) is overlaid in the contours as a reference. 
The  CoMFA  contour  maps  of  steric  and  electrostatic  ﬁelds  are  shown  in  Figures  2A  and  2B, 
respectively. In Figure 2A, two large regions of green contour close to the 3'-, 4'-, 5'-positions of the 
benzene  ring  indicate  that  bulky  substituents  are  preferred  in  those  positions.  Compounds  7 
(3',4',5'-triCl)  and  22  (3',4',5'-triCl)  completely  integrate  with  the  green  contours,  apparently 
responsible for their higher potencies than the corresponding analogs (compounds 1–4, 12, 40, 42, 43, 
47, 49) without -Cl at all these positions. Additionally, a small green contour near the -CF3 substituent 
at 6-position of the A ring explains why the binding affinity of compound 35 (6-propyl) is higher than 
that of the corresponding compound 29 (6-CH3). Some regions of yellow contour are noted near the 
amino  substitution  at  1-position  of  ring  A,  suggesting  that  a  bulky  group  appeared  there  would 
decrease the activity. This is in agreement with the fact that the substituent of compound 20 is too 
bulky to ﬁt into yellow region and thus is responsible for its weak inhibitory activity. Int. J. Mol. Sci. 2011, 12                         
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Figure 2. Stdev*coeff (A) steric, (B) electrostatic contour maps of ligand-based optimal 
CoMFA  model.  The  color  code  is  as  follows:  (A)  green  and  yellow  contours  indicate 
favorable and unfavorable bulky groups, respectively; (B) blue and red contours indicate 
favorable and unfavorable electropositive groups, respectively. The compound 58 in ball 
and stick is displayed as a reference. (Yellow atom: fluorine; red: oxygen; blue: nitrogen; 
green: chlorine; brown: bromine). 
 
Due to the strong electron-withdrawing ketone substituent, two large regions of blue contour above 
and below ring A, corroborate the favorability of partial positive charge in these regions. A small blue 
contour near 6-position of ring A suggests that an appropriate electropositive substituent at the position 
may lead to an increase in the binding affinity. This may explain why compound 29 shows decreased 
potency compared with compounds 24 (6-isopropyl) and 30 (6-butyl) by replacing the isopropyl or 
butyl group with an -CH3 group. Besides, a large red polyhedral near the amino substituent of ring A 
suggests  that  electronegative  substituents  are  well  tolerated  there.  The  fact  that  the  -CH2CF3  and 
-CH2CN substituents at 1-position of ring A of compounds 15 and 17 respectively are more beneficial 
to the activities than the -CH2COCH3 group of compound 16  is  just the case. Other red contours 
surrounding the -CF3 substituent of ring A allow us to speculate that electronegative substituent would 
increase  the  binding  affinities.  The  good  inhibitory  potencies  of  molecules  25(-CF2CF2CF3)  and 
33(-CN) are due to the orientations of these substituents towards the above red contours. In addition, a 
small red area also appears above the meta-position of the benzene ring. The above information offered 
from  the  CoMFA  contour  maps  is  helpful  for  us  to  further  explore  the  inhibitor-GABA   
receptor interactions. 
With respect to the steric and electrostatic contour maps, the information of contour maps obtained 
from the optimal CoMSIA model (Figures 3A and B) is mostly similar to that derived from above 
CoMFA one except for the different distribution ranges. The hydrophobic interaction in the CoMSIA 
model  is  represented  in  Figure  3C.  Two  large  orange  contours  surrounding  the  meta-position  of 
benzene ring demonstrate the importance of the -Cl group for the binding activity. Meanwhile, a super 
large white contour map sets around the 1-position of ring  A, suggesting the favor of hydrophilic 
groups for potency. When comparing compound 23 (-NHCOCH3) with 16 (-CH2COCH3), as well as 
22 (-NH2) with 7 (-CH3), it can be easily found that their activity discrepancies also attribute to this 
white  contour.  The  -CF3  group  of  ring  A  fills  into  several  large  white  contours,  indicating  that 
hydrophilic groups are essential for the inhibitory activity. Replacing -CH3 group (29) by -CN group 
(33) at C-6 leads to increased activity. Int. J. Mol. Sci. 2011, 12                         
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Figure 3. stdev*coeff (A) steric, (B) electrostatic, (C) Hydrophobic, (D) H-bond donor and 
(E) H-bond acceptor contour maps of  ligand-based optimal CoMSIA  model.  The color 
code is as follows: (A) green and yellow contours indicate favorable and unfavorable bulky 
groups,  respectively;  (B)  blue  and  red  contours  indicate  favorable  and  unfavorable 
electropositive groups, respectively; (C) orange and white contours indicate favorable and 
unfavorable  hydrophobic  groups,  respectively;  (D)  cyan  contours  indicate  favorable 
H-bond donor groups; (E) magenta contours indicate favorable H-bond acceptor groups. 
The compound 58 in ball and stick is displayed as a reference. (Yellow atom: fluorine; red: 
oxygen; blue: nitrogen; green: chlorine; brown: bromine) 
 
The CoMSIA contour maps of the hydrogen-bond donor and acceptor ﬁelds are shown in Figures 
3D and 3E, respectively. In Figure 3D, a large cyan contour appears enclosing the amino substituent of 
ring A, which suggests that the amino group acts as an H-bond donor by forming H-bond with the 
residue of the binding site. The cyan contour implies that an optimum H-bond donor group is expected 
to increase the activity, which agrees well with the fact that compounds 50–60 with the amino group at 
the N-1 show significantly increased potency compared to the analogous compounds 7 and 13–21. In 
the H-bond acceptor contour map, two magenta contours near two ketone groups of ring A indicate the 
importance of H-bond acceptor group for the binding activity. In addition, the presence of another 
magenta  contour  near  6-position  of  ring  A  reveals  the  extreme  importance  of  the  -CF3  group  in Int. J. Mol. Sci. 2011, 12                         
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6-position. 
The structural features obtained from above CoMSIA models are depicted in Figure 4. Changes in 
the binding affinity of the inhibitors could be rationalized by modifying the inhibitors based on these 
key structural features: (i) Electronegative hydrophilic polar substituents with minor/bulky size like 
-NH2/-CF3  groups  are  preferential  at  1-/6-positions  of  ring  A  respectively,  which  can  enhance  the 
activity of the inhibitor by providing a hydrogen bonding interaction with the protein target; (ii) Bulky 
electronegative substituents at 3'- and 4'-positions with a simultaneous big group at 5'-position of the 
benzene ring are beneficial for the enhanced potency of the inhibitors. 
Figure  4.  Structural  features  obtained  from  ligand-based  optimal  CoMSIA  model.  The 
common substructure of model compound 58 is shown in bold. 
 
2.3. Homology Modeling and Molecular Dynamics Simulation 
Although  the  subunit  composition  of  native  insect  GABA  receptor  is  unknown,  it  has  been 
confirmed that Rdl subunit can be expressed to form functional homo-oligomeric receptor [6], which 
has been used by Ian McGonigle to determine the critical features of GABA receptor agonists [23].The 
modeling of Rdl subunit was carried out based on the template of glutamate-gated chloride channel 
receptor in this work. It is known that both the GABA receptor and glutamate receptor are members of 
the  superfamily  of  Cys-loop  ligand-gated  ion  channels,  and  their  subunits  both  contain  four  TM 
regions. Since the Rdl subunit of housefly GABA receptor in the TM domains has a high level of 
sequence  identity  (47%)  with  the  template,  especially  in  the  TM2  domain  (62%).  The  multiple 
sequence alignment of TM domains between the Rdl subunit with the chains of glutamate receptor 
(shown in Figure 5) demonstrates that the TM domains between the GABA receptor and glutamate 
receptor  are  relatively  conserved,  suggesting  that  glutamate  receptor  structure  is  an  appropriate 
template for the modeling of the TM domains of GABA receptor. During the modeling process, the 
relative stability of the model was evaluated by the discrete optimized potential energy (DOPE), which 
scores of the template and the optimal modeled Rdl subunit are shown in Figure 6. Compared with the 
DOPE scores of the template, every residue of the model shows similar energy, suggesting that the 
loop reﬁnement is not necessary for the optimal model. The overview of the final modeled housefly Int. J. Mol. Sci. 2011, 12                         
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GABA receptor is shown in Figure 7. 
Figure 5. Alignments of the sequences of the TM domains between the Rdl subunit of 
housefly GABA receptor and the 3RHW chain A template. Different types of amino acids 
are depicted in different colors. The four transmembrane domains (TMDs) of Rdl subunit 
are  indicated with bold  lines and the positions  of the 2', 6' and 9' residues  in TM2 of   
Rdl  subunit  are  also  indicated.  “*”,  identical  residues;  “:”,  conserved  substitutions;   
“.”, semi-conserved substitutions. 
 
Figure 6. Discrete optimized potential energy (DOPE) score profiles of the template and 
modeled Rdl subunit. 
 
Figure 7. The final refined TM domains of the housefly GABA receptor shown in cartoon 
representation. Green: TM1, TM3, TM4; magenta: TM2. 
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To obtain the “real” bioactive conformation, 5 ns molecular dynamic simulation was employed to 
make the structure of the refined receptor more reasonable by considering both the impacts of the 
receptor flexibility and the effects of water solvation on the complex. The dynamical picture of the 
conformational changes is shown via the root-mean-square deviation (RMSD) in Figure 8.The RMSD 
of the trajectory with respect to the initial structure ranges from 1 to 5.5 Å, and reaches a plateau about 
5.3 Å after 3 ns, indicating that the structure conformation thereafter is stable and reliable for the 
subsequent docking study. 
Figure  8.  Plot  of  the  root-mean-square  deviation  (RMSD)  of  refined  GABA  receptor 
structure versus the MD simulation time. 
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2.4. Docking Analysis and Comparisons with 3D-Contour Map 
Docking, which plays an important role in the rational design of drugs, is frequently used to predict 
the binding orientation of drug candidates to their protein targets (active sites) and also to predict the 
binding affinity of the molecules in turn [24]. In the present study, dockings of all compounds into the 
housefly GABA receptor were carried out to find the optimal orientations of the compounds. Based on 
previous studies [10,12,16,25], we chose the T6' (Figure 5) residue of Rdl subunit as the active site in 
the chloride ion channel to conduct the docking of the most potent compound 58. The analyze of the 
top 10 scored (4.49–2.23) docking poses (as shown in Figure 9) shows that the top 5 scored poses 
display similar orientations (shown as orientation I) while the seventh and tenth scored poses show the 
opposite orientations  (orientation  II).  From  these  poses, the  structural  conformation  of  the  highest 
scored pose is adopted since it has the highest binding free energy and also is well consistent with the 
QSAR contour maps as mentioned below in docking analysis. More importantly, the binding sites of 
the docking model are in accordance with site-directed mutation assays [5,12,16], which imply that 
amino acids A2', T6' and L9' (Figure 5) in TM2 region play key roles in the inhibitor recognition. 
However, the sixth and ninth scored conformations have a different orientation (orientation III) with 
other poses, which results in changing the steric environment of the compound to decrease the score 
and create the weak binding pattern. Combined, the obtained structural conformation with compound 
58 is considered to be the optimal docking model (as shown in Figure 10).   Int. J. Mol. Sci. 2011, 12                         
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Figure 9. The structural conformations of the top 10 scored poses. Blue: orientation I;   
red: orientation II; yellow: orientation III. 
 
Figure 10. Docking of model compound into the GABA binding sites. Model compound 
and  residues  within  4.5  Å  are  shown  as  stick  representation.  Hydrogen  bonding 
interactions are shown as red dashed lines. Yellow and magenta: carbon; red: oxygen; blue: 
nitrogen; cyan: fluorine; green: chlorine; brown: bromine. 
 
In Figure 10, the key residues that form the binding pocket of GABA receptor are Val-186(B), 
Thr-187(B), Leu-190(B), Ala-183(C), Thr-187(C), Val-182(D), Ala-183(D), Val-186(D), Thr-187(D), 
Ala-180(E), Leu-184(E) and Thr-187(E), which are located in the TM2 regions of four segments. The 
model compound  is  anchored  in  the  binding  pocket  via  several  H-bonds.  The  amide  of  ring  A  is 
capable of  making similar H-bonds with the backbone carbonyl of  Ala-183(C) (-NH•••O, 3.89 Å, Int. J. Mol. Sci. 2011, 12                         
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108.3°) and the side chain hydroxyl group of Thr-187(D) (-NH•••O, 3.60 Å, 75.8°) as H-bond donors, 
which are consistent with the cyan contours at the H-bond contour maps (Figure 3D) near this position. 
These H-bonding interactions of the amide indicate that the potential H-bond-donating NH plays a 
critical  role  in  the  binding  activity.  Additionally,  ketone  groups  at  2-  and  4-positions  as  H-bond 
acceptors prefer to construct H-bonds with the side chain hydroxyl groups of Thr-187(D) (-OH•••O, 
3.54 Å, 97.4°) and Thr-187(E) (-OH•••O, 3.38 Å, 162.2°), respectively. It is remarkable to note that the 
-CF3 group of ring A forms a weak H-bond (5.60 Å) with the backbone NH of Thr-187(B). These 
observations  as  mentioned  above  are  in  full  agreement  with  the  H-bond  accepter  contour  map   
(Figure 3E). As an outlier in the ligand-based model, compound 21 shows little different orientation in 
the docking pocket, and  is also considered to be an outlier  in the structure-based  model.  For this 
compound, the absence of H-bond-donating substituent at 1-position of the ring A only results in the 
H-bond formation between its ketone groups and the side chains of Thr-194(C) and Thr-194(D) in the 
binding pocket, indicating the weak binding pattern of this compound. This clearly demonstrates why 
compound 21 is so low in activity compared with compound 58 (pKi = 9.3). 
The docked model shows that the amide of ring A fits nicely into a relatively large pocket composed 
by Ala-183(C), Thr-187(C) and Thr-187(D), indicating that the steric interaction in this hydrophilic 
region  is  deleterious  to  the  inhibitory  activity.  However,  compared  with  compound  58,  the  large 
-CH2C(CH3)3  substituent  of  compound  14  leads  to  steric  bump  with  Thr-194(A)  and  Thr-194(E) 
residues and disturb the optimal position of the compound in the pocket, which is one reason of the 
poor activity of compound 14 (pKi = 6.2, an outlier in the model). This result is well consistent with 
the steric contour map of the CoMSIA model, which owns a yellow contour (Figure 3A) at the same 
location. Residues Val-186(B), Thr-187(B) and Leu-190(B),  not only  form a sufficient hydrophilic 
room to accommodate a large hydrophobic -CF3 substituent,  but also are suitable  for electrostatic 
interactions with negatively charged -CF3 group, which  indicates that a bulky and electronegative 
substituent at this position would be favorable to the activity. Figure 10 also shows a comparatively 
large  empty  space  formed  by  hydrophobic  residues  Val-182(D),  Ala-183(D),  Ala-180(E)  and 
Leu-184(E) around the benzene ring, suggesting that a suitable bulky electronegative substituent on the 
benzene ring is needed and would have a favorable interaction with the backbone NH of Val-182(D) 
and Ala-183(D). The blue contour above the A ring (Figure 3B) implying an electropositive favorable 
region, is consistent with the appearance of Val-186(D) and Thr-187(D) surrounding this area. These 
observations are also demonstrated by the presence of several green and red contours (Figures 3A, 3B 
and 3C) around these regions. Overall, the results indicate that the binding model obtained from the 
docking analysis is reasonable and suggest that the amide and ketone groups play major roles in the 
high binding potencies of these inhibitors of the GABA receptor. 
2.5. Binding Mode for APDs in the Housefly GABA Receptor 
To identify the binding sites of NCAs in GABA-gated chloride channels, some mutagenesis studies 
show that the amino acids include Ala2 (A2'), Leu3 (L3'), Thr6 (T6') and Leu9 (L9') (index numbers 
for the TM2 region) in the channel lumen are responsible for the interactions of NCAs [10,12,16,25]. 
Correspondingly, as illustrated in our docking model of the complex (Figure 10), the model compound 
fits  into the putative  binding pocket lined by  ﬁve TM2 segments  in the channel. The analyses  of Int. J. Mol. Sci. 2011, 12                         
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H-bond interactions in the docking complex indicate that A2' (Ala-183) and T6' (Thr-187) (Figures 5 
and 10) play key roles in the inhibiting interaction of APDs with housefly GABA receptor, which is 
consistent with earlier mutagenesis study in the β3 homopentamer that A2' and T6' mutations reduce or 
destroy the NCA radioligand binding [16]. In addition, A-1' (Ala-180), 1'V (Val-182), A2' (Ala-183), 
L3' (Leu-184), V5' (Val-186), T6' (Thr-187) and L9' (Leu-190) residues without H-bonding contacts 
with  the  compound,  are  likely  to  contribute  to  the  APDs’  binding  by  maintaining  the  structural 
integrity of the binding site, or mediating the local conformational movements near the binding site. 
However, the binding sites for APDs focusing on the A2' and T6' in TM2 region are shared as two 
identical key sites with other antagonists, such as fipronil, picrotoxinin and EBOB [5,12,16]. Although 
the amino acids V5' and L9' of Rdl subunit are indirectly involved in the binding of APDs, the amino 
acids at 5' and 9' positions in TM2 region are also two potential sites responsible for the binding of 
NCAs, while the  fipronil-related NCAs [10,12] are  in hydrophobic contact with I5' and  L9' of  β3 
subunit. Whereas, compared with fipronil [2], S17' residues within the channel does not exist in the 
interaction of APDs. In summary, structurally different classes of NCAs bind to two identical sites and 
two  potential  sites  in  different  or  overlapping  orientations  within  the  channel  pore  of  the  GABA 
receptor, except for a few NCAs with multiple sites.   
3. Materials and Methods 
3.1. Dataset 
Presently,  sixty  3-arylpyrimidin-2,4-diones  derivatives  acting  on  housefly  GABA-gated  chloride 
channel collected from reference [9] were used as dataset with a wide activity ranging from 3.8 to 9.3 
(pKi values), which was then divided  into a training set and a test set in a ratio of 3:1 based on 
adequate coverage in terms of both the inhibitory activity and the structural diversity. The training set 
was used to construct 3D-QSAR models and the test set (asterisked molecules in Table 1) was used for 
the model validation. Table 2 shows the structures and biological data (pKi) of all compounds. 
Table 2. Structures and inhibitory activities of all 3-arylpyrimidin-2, 4-diones (APDs) in the dataset. 
N
N R2
O
O
R1
X
2
4
3
6
5  
No  X  R1  R2  pKi 
a  No  X  R1  R2  pKi 
a 
1  4-Cl  CH3  CF3  5.4  31  3-Cl,4-Cl,5-Cl  CH3  CH2SCH3  4.6 
2  3-Cl  CH3  CF3  5.8  32  3-Cl,4-Cl,5-Cl  CH3  COOH  4.0 
3  3-Cl,5-Cl  CH3  CF3  6.8  33  3-Cl,4-Cl,5-Cl  CH3  CN  6.2 
4 
#  3-Cl,4-Cl  CH3  CF3  6.6  34  3-Cl,4-Cl,5-Cl  CH3  CH2CH2CF3  6.4 
5 
#  2-Cl,3-Cl  CH3  CF3  6.6  35  3-Cl,4-Cl,5-Cl  CH3  CH2CH2CH3  6.2 
6 
#  2-Cl,6-Cl  CH3  CF3  5.6  36  3-Cl,4-Cl,5-Cl  CH3  CF2CF2CF2CF3  5.0 
7 
#  3-Cl,4-Cl,5-Cl  CH3  CF3  8.0  37  3-Cl,4-Cl,5-Cl  CH3  2-F-phenyl  4.0 
8  2-Cl,3-Cl,5-Cl  CH3  CF3  7.4  38 
#  3-Cl,4-Cl,5-Cl  CH3  4-F-phenyl  5.0 Int. J. Mol. Sci. 2011, 12                         
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Table 2. Cont.
 
No  X  R1  R2  pKi 
a  No  X  R1  R2  pKi 
a 
9  2-Cl,4-Cl,6-Cl  CH3  CF3  5.2  39 
#  3-Cl,4-Cl,5-Cl  CH3  Cl  5.6 
10  2-Cl,3-Cl,6-Cl  CH3  CF3  7.6  40 
#  4-Cl  NH2  CF3  6.7 
11  2-Cl,4-Cl,5-Cl  CH3  CF3  7.1  41 
#  2-Cl,4-Cl  NH2  CF3  7.5 
12  -H  CH3  CF3  4.0  42  3-Cl,5-Cl  NH2  CF3  7.7 
13  3-Cl,4-Cl,5-Cl  CH(CH3)2  CF3  6.5  43 
#  3-Cl,4-Cl  NH2  CF3  7.7 
14 
#  3-Cl,4-Cl,5-Cl  CH2C(CH3)3  CF3  6.2  44  2-Cl,4-Cl,5-Cl  NH2  CF3  7.5 
15  3-Cl,4-Cl,5-Cl  CH2CF3  CF3  7.2  45 
#  2-Cl,4-Cl,6-Cl  NH2  CF3  7.5 
16  3-Cl,4-Cl,5-Cl  CH2COCH3  CF3  3.8  46  2-Cl,6-Cl  NH2  CF3  7.1 
17  3-Cl,4-Cl,5-Cl  CH2CN  CF3  7.4  47  3-Cl  NH2  CF3  6.5 
18  3-Cl,4-Cl,5-Cl  CH2Ph  CF3  3.9  48  2-Cl,3-Cl,4-Cl  NH2  CF3  8.5 
19  3-Cl,4-Cl,5-Cl  CH2CH2OCH3  CF3  6.6  49  -H  NH2  CF3  5 
20  3-Cl,4-Cl,5-Cl  CH2CH2CH2CH3  CF3  4.0  50  3-Cl,4-I,5-Cl  NH2  CF3  9.3 
21 
#  3-Cl,4-Cl,5-Cl  H  CF3  5.5  51  3-Cl,4-SOCH3,5-Cl  NH2  CF3  7.5 
22  3-Cl,4-Cl,5-Cl  NH2  CF3  8.8  52  3-Cl,4-SCH3,5-Cl  NH2  CF3  8.7 
23  3-Cl,4-Cl,5-Cl  NHCOCH3  CF3  5.3  53 
#  3-Cl,4-Ph,5-Cl  NH2  CF3  8.9 
24  3-Cl,4-Cl,5-Cl  CH3  CH(CH3)2  6.3  54  3-Cl,4-OCH3,5-Cl  NH2  CF3  8.5 
25  3-Cl,4-Cl,5-Cl  CH3  CF2CF2 CF3  7.3  55  3-Cl,4-(2-thienyl),5-Cl  NH2  CF3  9.1 
26  3-Cl,4-Cl,5-Cl  CH3  CH2O CH3  5.1  56 
#  3-Cl,4-N(CH3)2,5-Cl  NH2  CF3  8.8 
27  3-Cl,4-Cl,5-Cl  CH3  Ph  4.0  57  3-Cl,4-OCH(CH3)2,5-Cl  NH2  CF3  9.0 
28  3-Cl,4-Cl,5-Cl  CH3  CH2SO2 CH3  42  58  3-Cl,4-Br,5-Cl  NH2  CF3  9.3 
29  3-Cl,4-Cl,5-Cl  CH3  CH3  4.6  59  3-Cl,4-CF2CF3,5-Cl  NH2  CF3  8.8 
30  3-Cl,4-Cl,5-Cl  CH3  C(CH3)3  7.5  60 
#  3-F,4-CF3,5-F  NH2  CF3  8.7 
# Test set compound; 
a obtained from 
3[H] EBOB binding assay using housefly head tissue. 
3.2. Molecular Modeling and Alignment 
Molecular  modeling  and  alignment  were  carried  out  by  using  the  SYBYL  package  (Tripos 
Associates, St. Louis, MO, USA). The energy optimization of each compound with Gasteiger-Huckel 
charges  was  performed  using  the  Tripos  force  field  [26]  with  a  distance-dependent  dielectric  and 
Powell  gradient  algorithm  with  a  convergence  criterion  of  0.05  kcal/mol.  To  obtain  the  optimal 
3D-QSAR  statistical  model,  two  different  alignment  rules,  i.e.,  the  ligand-  and  receptor-based 
alignments were adopted to identify the most efﬁcient alignment approach for this data set. In the first 
approach,  all  compounds  were  aligned  to  the  most  potent  compound  58  by  the  Align-Database 
function  using  the  common  substructure  (Figure  11).  For  the  second  method,  the  bioactive 
conformations of all compounds were firstly derived from docking and then processed using the first 
method. The resulting ligand-/receptor-based alignment models are shown in Figure 11. Int. J. Mol. Sci. 2011, 12                         
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Figure  11.  The  alignment  models  of  all  compounds:  (A)  ligand-based  alignment;   
(B)  receptor-based  alignment;  (C)  The  common  substructure  of  compound  58  for 
alignment is shown in bold. 
 
3.3. Homology Modeling and Molecular Dynamics Simulation   
Protein sequence of Rdl subunit in Musca domestica (house fly) GABA receptor (ID AAC23602) 
was retrieved from the NCBI web site [27]. Before homology modeling, the sequence was edited to 
remove the extracellular region and residues in the loop between transmembrane (TM) domains 3 and 
4 due to unavailable original template and their no contribution to the binding of NCAs. The TM 
domains were modeled using MODELLER software [28] with the template of X-ray crystal structure 
of glutamate-gated chloride channel receptor (PDB code 3RHW, 3.26 Å) based on the sequence and 
structure  comparison  of  the  TM  domains  of  GABA-gated  chloride  channel  receptor. The  multiple 
sequence alignment of TM domains between the Rdl subunit with the chains of glutamate receptor was 
carried out using the ClustalW program [29]. To evaluate the fold of the optimal model, the discrete 
optimized  potential  energy  score of  each  residue  was  calculated  by  using  MODELLER  [30].  The 
pentameric  GABA  receptor  was  created  by  superimposing  the  optimal  monomer  onto  the 
corresponding monomers of the template, followed by energy optimization using MD simulation to 
remove the steric clashes at the subunits interfaces. 
The MD simulation was carried out using theGromacs4.0 package [31]. GROMOS96 43a1 force 
ﬁeld  [32]  was  used  to  describe  the  protein  parameters.  A  rectangular  box  with  a  side  length  of   
95.49 Å × 96.65 Å × 101.01 Å was applied for the system, which was neutralized by adding 5 Na
+ 
counterions and then solvated in a truncated octahedral box of SPC waters with [33] a margin distance 
of  10  Å.  All  bonds  involving  hydrogen  were  constrained  using  the  LINCS  algorithm  [34].  The 
long-range  electrostatic  interaction  was  calculated  by  using  the  particle-mesh-Ewald  (PME)   
method [35] with a cutoff of 10.0 Å. All simulations were performed at constant temperature (300 K) 
and pressure (1 atm) using the Berendsen coupling algorithm [36] under periodic boundary conditions. 
Prior to MD simulation, the whole system was subjected to 10,000 steps of energy minimization to 
relieve the geometric strain and close intermolecular contacts. The minimized system was gradually 
heated up to and maintained at 300 K with a coupling coefficient of 1.0/ps in a pressure-constant 
period of 50 ps. Subsequently, a 500 ps Langevin dynamics calculation was performed with a 2 fs time 
step at constant temperature (300 K) and pressure (1 atm). Finally, the production phase was run for 5 ns 
with a 2 fs time step. Coordinate trajectories were recorded every 2 ps during the entire simulation process. Int. J. Mol. Sci. 2011, 12                         
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3.4. Docking 
To  predict  the  appropriate  interaction  of  APDs  with  housefly  GABA  receptor,  molecular   
docking was performed to dock all compounds into the active site of the GABA receptor using the 
Surflex  module  of  SYBYL.  During  Surflex-docking,  two  parameters,  i.e.,  protomol-bloat  and 
protomol-threshold were used to define the protomol, which is a computational representation of the 
intended binding site where putative ligands are aligned [37]. The putative poses of docked compounds 
were scored using the Hammerhead scoring function, which also served as an objective function for 
local optimization of poses [38]. According to each scoring function, the highest-ranking poses for all 
compounds were aligned together for CoMFA and CoMSIA modeling.   
3.5. 3D-QSAR Analysis 
In  CoMFA,  the  steric  and  electrostatic  interactions  of  the  probe  atoms  with  each  atom  in  the 
molecule were computed by using the Tripos force ﬁeld [26] with radius 1 Å and charge +1 in a 
regularly spaced (2 Å) grid. The steric and electrostatic energy values were truncated at a default value 
(30 kcal/mol). Five similarity index descriptors of CoMSIA–steric (S), electrostatic (E), hydrophobic 
(H), hydrogen bond donor (D) and hydrogen bond acceptor (A), were calculated using the same lattice 
box used in the CoMFA calculations with the standard settings: charge +1, radius 1 Å, hydrophobicity 
+1, hydrogen bond donating +1, hydrogen bond accepting +1 [37]. CoMSIA similarity indices (AF) for 
a molecule j with atoms i at the grid point q are calculated by Equation (1) as follows:   
 
2
, ,
iq ar q
F K probe k ik A j e  
     (1) 
where k represents the steric, electrostatic, hydrophobic, hydrogen-bond donor and acceptor properties; 
i is the summation index over all atoms of the molecule j under investigation; ωik is the actual value of 
the physicochemical property k of atom i; riq is the mutual distance between probe atom at grid point q 
and atom i of the test molecule; ωprobe,k is the value of the probe atom. The attenuation factor α was set 
to the default value of 0.3.   
Partial least-squares (PLS) method was used to linearly correlate the CoMFA/CoMSIA descriptors 
to  the  binding  affinity  values.  The  optimal  number  of  PLS  components  was  determined  by 
leave-one-out  (LOO)  cross-validation  method  with  a  cross-validation  coefficient  (q
2).  Using  the 
optimum  number  of  components,  non-cross-validated  correlation  coefﬁcient  (r
2
ncv)  was  calculated 
subsequently.  The  predictive  correlation  coefﬁcient  r
2
pred,  based  on  the  test  set  molecules,  was 
calculated by Equation (2) as follows: 
r
2
pred = 1 − (PRESS/SD)  (2) 
where SD is the sum of squared deviations between the biological activities of the test set molecules 
and the mean activities of the training set molecules, and PRESS is the sum of squared deviation 
between  the  actual  and  predicted  activities  of  the  test  set  molecules.  Finally,  CoMFA/CoMSIA 
coefficient maps were generated by interpolation of the pairwise products between the PLS coefﬁcients 
and the standard deviations of the corresponding CoMFA and CoMSIA descriptor values. Int. J. Mol. Sci. 2011, 12                         
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4. Conclusion 
In  this  work,  the  ligand-  and  receptor-based  3D-QSAR  studies  on  60  APDs  of  insect  GABA 
receptor inhibitors are performed using CoMFA and CoMSIA tools. From the resultant models, the 
reasonable statistical properties prove that the 3D-QSAR models developed in this work are stable and 
statistically reliable. The resulting contour maps generated from the best CoMFA and CoMSIA models 
correlate well with the structural and functional features of APDs in the binding site. On the other hand, 
the three-dimensional model of housefly GABA receptor is generated by homology modeling with the 
X-ray  crystal  structure  of  the  glutamate-gated  chloride  channel  receptor  as  a  template.  Molecular 
docking was employed to elucidate the potential binding mode of APDs inhibitors in the housefly 
GABA receptor, which reveals that some residues, such as A2' and T6' in TM2 region of Rdl subunit, 
play  important  roles  in  the  inhibitor  binding.  In  conclusion,  the  good  consistency  between  the 
3D-QSAR  and  docking  results  proves  again  the  robustness  of  the  3D-QSAR  models  and  the 
reasonability  of  the  docking  model,  which  can  be  utilized  in  future  rational  design  of  novel   
potential insecticides. 
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